Merck & Co., Inc.
MRK
$148.35
-$1.19-0.80%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.64% | 2.89% | 1.31% | 1.68% | 1.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.64% | 2.89% | 1.31% | 1.68% | 1.82% |
| Cost of Revenue | 11.64% | 4.43% | 0.80% | -3.78% | -5.02% |
| Gross Profit | 2.60% | 2.43% | 1.47% | 3.35% | 4.00% |
| SG&A Expenses | 4.17% | 0.87% | 0.13% | 0.21% | 2.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.78% | 5.86% | 4.71% | -20.34% | -11.27% |
| Operating Income | -24.12% | -1.72% | -3.82% | 62.51% | 32.91% |
| Income Before Tax | -68.96% | -42.34% | 5.67% | 59.02% | 25.65% |
| Income Tax Expenses | 1.28% | -0.81% | 0.07% | 78.10% | 83.18% |
| Earnings from Continuing Operations | -80.70% | -48.81% | 6.59% | 56.57% | 19.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 133.33% | 105.88% | 50.00% | 33.33% | 25.00% |
| Net Income | -80.66% | -48.75% | 6.64% | 56.68% | 19.44% |
| EBIT | -24.12% | -1.72% | -3.82% | 62.51% | 32.91% |
| EBITDA | -17.00% | 0.57% | -1.96% | 51.84% | 29.53% |
| EPS Basic | -80.71% | -48.34% | 7.88% | 57.90% | 19.91% |
| Normalized Basic EPS | -27.28% | -2.76% | -4.14% | 65.44% | 37.54% |
| EPS Diluted | -80.74% | -48.30% | 8.24% | 58.71% | 20.41% |
| Normalized Diluted EPS | -27.20% | -2.60% | -4.03% | 65.89% | 37.89% |
| Average Basic Shares Outstanding | -1.77% | -1.61% | -1.20% | -0.68% | -0.33% |
| Average Diluted Shares Outstanding | -1.92% | -1.79% | -1.34% | -0.82% | -0.44% |
| Dividend Per Share | 5.06% | 5.13% | 5.19% | 5.26% | 5.33% |
| Payout Ratio | 4.34% | 1.02% | -0.02% | -0.33% | -0.12% |